NCT05402839View on ClinicalTrials.gov

Screening of Malignant Hyperthermia Susceptible Individuals

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 22, 2022

Primary Completion Date

February 28, 2041

Study Completion Date

February 28, 2041

Conditions
Malignant Hyperthermia
Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER